SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013304
Filing Date
2022-08-11
Accepted
2022-08-11 16:20:49
Documents
64
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q agrx-20220630x10q.htm   iXBRL 10-Q 1488939
2 EX-31.1 agrx-20220630xex31d1.htm EX-31.1 10622
3 EX-31.2 agrx-20220630xex31d2.htm EX-31.2 10550
4 EX-32.1 agrx-20220630xex32d1.htm EX-32.1 5936
5 EX-32.2 agrx-20220630xex32d2.htm EX-32.2 5889
  Complete submission text file 0001558370-22-013304.txt   6070470

Data Files

Seq Description Document Type Size
6 EX-101.SCH agrx-20220630.xsd EX-101.SCH 47246
7 EX-101.CAL agrx-20220630_cal.xml EX-101.CAL 42578
8 EX-101.DEF agrx-20220630_def.xml EX-101.DEF 203015
9 EX-101.LAB agrx-20220630_lab.xml EX-101.LAB 412097
10 EX-101.PRE agrx-20220630_pre.xml EX-101.PRE 316073
58 EXTRACTED XBRL INSTANCE DOCUMENT agrx-20220630x10q_htm.xml XML 824828
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36464 | Film No.: 221156179
SIC: 2834 Pharmaceutical Preparations